A study of anti-SARS-CoV-2 antibodies among healthcare personnel and the general population
Bulgaria, like many other countries, has experienced the far-reaching consequences of the Coronavirus disease 2019 (COVID-19) pandemic. Seroprevalence studies serve as a crucial method for assessing the exposure and immunity levels within a population. In this serosurvey, which is the first of this...
Saved in:
| Main Authors: | Iva Trifonova, Kim Ngoc, Teodora Gladnishka, Vladislava Ivanova, Metodi Kunchev, Ventsislav Mutafchiyski, Iva Christova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-03-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2023.2256417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023)
by: Kim Ngoc, et al.
Published: (2025-01-01) -
Antibody dynamics and viral load in COVID-19: differences in mild, moderate and severe cases
by: Kim Ngoc, et al.
Published: (2023-03-01) -
Evaluation of SARS-CoV-2 seroprevalence among clinical laboratory workers and its association with past exposure to infection and vaccination
by: Humaira Ahmed, et al.
Published: (2024-12-01) -
Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV
by: chiara papalini, et al.
Published: (2020-10-01) -
Seroprevalence of SARS-CoV-2 in Children Admitted to a Pediatric Ward of an Urban Hospital
by: Rama Kaja, et al.
Published: (2022-12-01)